Research Grants 4 show all


$758.1K
2006

$364.1K
2007

$357.2K
2008

Patents 396show all

  • 188
    A61K - Preparations for medical, dental, or toilet purposes
  • 176
    C12N - Microorganisms or enzymes
  • 31
    C07K - Peptides
  • 14
    C12Y - Enzymes
  • 9
    C07D - Heterocyclic compounds
  • 8
    C07H - Sugars
  • 8
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 7
    A01K - Animal husbandry
  • 6
    B82Y - Specific uses or applications of nanostructures
  • 6
    C07C - Acyclic or carbocyclic compounds

Clinical Trials 3show all

3Phase 2

SEC Filings show all


232
8-K

69
10-Q

17
10-K

11
D

1
S-1

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2014-03-13$6,000,000$6,000,000Equity, Option to Acquire, Security to be Acquired
2012-01-13$5,172,574$172,574Equity, Option to Acquire, Security to be Acquired
2010-08-05$44,000,000$44,000,000Equity
2003-09-22Unknown Unknown Other (Paper Filing)

Key Executives

  • J. Michael French
    Executive Officer, Director
  • Peter S. Garcia
    Executive Officer
  • Barry Polisky
    Executive Officer
  • James M. Karis
    Director
  • Gregory Sessler
    Director
  • Peter D. Parker
    Director
  • Chiang J. Li
    Director
  • Michael D. Taylor
    Director
  • Philip C. Ranker
    Executive Officer
  • R. John Fletcher
    Director
  • Richard T. Ho
    Executive Officer
  • Stefan Loren
    Director
  • Joseph W. Ramelli
    Director